首页> 外文OA文献 >Liposomal Drug Delivery of Anticancer Agents:Synthesis, Biophysical Characterization and Biological Studies of Enzyme Sensitive Phospholipid Prodrugs
【2h】

Liposomal Drug Delivery of Anticancer Agents:Synthesis, Biophysical Characterization and Biological Studies of Enzyme Sensitive Phospholipid Prodrugs

机译:抗癌药物的脂质体药物传递:酶敏感性磷脂前药的合成,生物物理表征和生物学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the first part of the thesis the work towards a new generation of liposomal drug delivery systems for anticancer agents is described. The drug delivery system takes advantage of the elevated level of secretory phospholipase A2 (sPLA2) IIA in many tumors and the enhanced permeability and retention (EPR) effect. The liposomes consists of sPLA2 IIA sensitive phospholipids having anticancer drugs covalently attached to the sn-2 position of the glycerol backbone in the phospholipids, hence drug leakage is avoided from the carrier system. Various known anticancer agents, like chlorambucil, all-trans retinoic acid, α-tocopheryl succinate and calcitriol were examined for their ability to be incorporated into the investigated drug delivery system and syntheses of the phospholipid prodrugs are described. The majority of the phospholipid prodrugs were able to form particles with diameters close to 100 nm upon extrusion at 20 °C indicating that unilamellar vesicles are formed. When subjected to sPLA2 the phospholipid prodrugs were converted into cytotoxic lysolipids and along with the released anticancer drug a chemotherapeutic cocktail is formed. Cytotoxicity studies in several cancer lines revealed that upon sPLA2 triggering the formulated phospholipid prodrugs displayed IC50 values in range from 3–36 μM and complete cell death was observed when higher drug concentrations were applied. Promising for the drug delivery system the majority of the phospholipid prodrugs remain non-toxic in the absence of the enzyme meaning the prodrugs will not damage healthy tissue during the transport in the body. In the second part of the thesis the synthetic studies towards a library of small naturalproduct- like molecules are described. The collection of molecules was synthesized via a diversity oriented synthesis (DOS) based strategy using a limited number of reaction types. Upon coupling of unsaturated building blocks ring closing metathesis cascades were used to “reprogram” the molecular scaffold and highly diverse structures were obtained. In total 20 novel compounds with a broad structural diversity were prepared in 5 or 6 synthetic steps.
机译:在论文的第一部分中,描述了用于抗癌药的新一代脂质体药物递送系统的工作。该药物递送系统利用了许多肿瘤中分泌性磷脂酶A2(sPLA2)IIA的水平升高以及通透性和保留(EPR)效果增强的优势。脂质体由sPLA2 IIA敏感的磷脂组成,它们的抗癌药共价连接到磷脂中甘油主链的sn-2位,因此避免了药物从载体系统中泄漏。检查了各种已知的抗癌剂,如苯丁酸氮芥,全反式维甲酸,琥珀酸α-生育酚酯和骨化三醇的能力,以将其掺入所研究的药物递送系统中,并描述了磷脂前药的合成。在20°C挤出后,大多数磷脂前药能够形成直径接近100 nm的颗粒,表明形成了单层囊泡。当进行sPLA2处理时,磷脂前药被转化为细胞毒性溶血脂,并与释放的抗癌药一起形成化学疗法的混合物。在一些癌症细胞系中的细胞毒性研究表明,在sPLA2触发配制的磷脂前药后,其IC50值范围为3–36μM,使用较高的药物浓度可观察到完全细胞死亡。对于药物输送系统而言,大多数磷脂前药在没有酶的情况下仍保持无毒状态,这意味着前药在体内运输过程中不会损害健康组织。在论文的第二部分中,描述了对类似天然产物的小分子文库的综合研究。分子的收集是通过使用有限数量的反应类型通过基于多样性导向合成(DOS)的策略合成的。结合不饱和结构单元后,使用闭环复分解级联反应对分子支架进行“重编程”,并获得高度多样化的结构。在5或6个合成步骤中,总共制备了20种具有广泛结构多样性的新型化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号